Abiodun Ogunniyi

Research Interests

Antimicrobial Resistance Bacteriology Biochemistry & Molecular Biology Clinical Microbiology Drug discovery Gene Expression Medical Bacteriology Medical Microbiology Vaccinology Veterinary Microbiology

Dr Abiodun Ogunniyi

NHMRC Externally-Funded Research Associate Professor

School of Animal and Veterinary Sciences

College of Sciences

Eligible to supervise Masters and PhD - email supervisor to discuss availability.

My research program broadly aims to gain a deep understanding of how bacterial pathogens interact with their hosts to cause disease. I then apply the information gleaned from such investigations to prevent or treat the infections through vaccination or using new antimicrobial agents and novel biocides. I also integrate food safety, environmental, human and animal health research as a “One Health” approach to managing infections caused by multidrug-resistant pathogens (superbugs) through antimicrobial stewardship, for better public health outcomes. To achieve these objectives, I use a combination of molecular, cellular and immunological techniques and imaging of light-emitting microorganisms during infection in living mice (in vivo bioluminescence imaging).

I have a keen interest in understanding the molecular mechanisms of bacterial pathogenesis, with emphasis on the characterisation of virulence factors and evaluating the potential of candidate vaccine antigens.  My PhD was conducted under the joint supervision of Professor Paul Manning, Professor Ieva Kotlarski, and Associate Professor Renato Morona and entailed the functional characterisation of the SefA protein of Salmonella enterica serovar Enteritidis.

I carried out my postdoctoral work in Professor James Paton’s laboratory from March 1997 to December 2009 on the molecular analysis of pneumococcal pathogenesis, and became an independent Senior Research Fellow in January 2010.

I joined the Australian Centre for Antimicrobial Resistance Ecology (ACARE; Director - Prof Darren Trott) in January 2015, where my research focusses on efficacy assessments of new broad-spectrum antimicrobials to address the rising incidence of multidrug-resistant bacterial pathogens. I also assess efficacy evaluation of biocides (such as the pH-neutral electrolysed oxidising water) for wide application in health, agriculture and food industries.

Throughout my research career, I have contributed significantly to the design and execution of research projects, international research grant applications and development of new technologies. I have significantly harnessed my expertise and experience to supervise and mentor numerous Honours, MSc and PhD candidates, and I actively collaborate with national and international colleagues and postdoctoral fellows to achieve mutual success in our research activities.

A significant aspect of my research also involves extensive engagement and consultation with Industry to promote research translation into community benefit through commercialisation.

I have a series of interwoven projects in my research program:

In vitro activity testing of novel antimicrobial agents and development of bioluminescent mouse models for preclinical testing of the agents to treat bacterial and fungal infections

Molecular analysis of bacterial pathogenesis

Efficacy evaluation of new biocides

Serotype-independent pneumococcal vaccines

In vivo gene expression

 

 

Date Position Institution name
2024 - ongoing Associate Professor The University of Adelaide
2023 - 2028 Chief Investigator The University of Adelaide
2023 - 2026 NHMRC Externally-Funded Research Fellow The University of Adelaide
2022 - ongoing Group leader, novel drug discovery and preclinical evaluation program The University of Adelaide
2017 - 2020 Senior Research Fellow (C) University of South Australia
2015 - 2023 University Senior Postdoctoral Researcher (C) The University of Adelaide
2010 - 2014 Senior Research Fellow (C) The University of Adelaide
2001 - 2009 Senior Research Officer (B) Women's and Children's Hospital and The University of Adelaide
1997 - 2000 Research Officer (A) Women's and Children's Hospital

Date Type Title Institution Name Country Amount
2024 Award ASA 2024 Travel Award Australian Society for Antimicrobials Australia AU$2,500.00
2022 Fellowship Fellow, Australian Society for Microbiology (FASM) The Australian Society for Microbiology Australia -
2012 Achievement Research Career Development Network (RCDN) Achievement Award The University of Adelaide Australia -
2007 Award Research Career Development Network (RCDN) Travel Award The University of Adelaide Australia -
1991 Scholarship Equity and Merit Scholarship Award Australian International Development Assistance Bureau (AIDAB, now Australian Agency for International Development [AusAID]) Australia -

Language Competency
English Can read, write, speak, understand spoken and peer review
Yoruba Can read, write, speak and understand spoken

Date Institution name Country Title
1991 - 1996 The University of Adelaide Australia PhD
1987 - 1989 Obafemi Awolowo University Nigeria MSc
1982 - 1986 University of Jos Nigeria BSc (First Class Honours)

Date Title Institution name Country
2022 Fellow, The Australian Society for Microbiology (FASM) The Australian Society for Microbiology (ASM) Australia

Year Citation
2025 Khan, J. A., Ogunniyi, A. D., Brunetti, G., Drigo, B., Shah, N. S., Al-Anazi, A., & Donner, E. (2025). Effective disinfection of antibiotic resistant bacteria and antibiotic resistance genes from water using chlorination, UV and UV/H2O2. Process Safety and Environmental Protection, 202(Part A), 107589.
DOI Scopus1 WoS1
2025 Abdo, A. I., Nguyen, H. T., Kaul, L. D., Schmitt-John, T., Kopecki, Z., Ogunniyi, A. D., & Richter, K. (2025). Plasma-activated water accelerates wound healing and reduces Staphylococcus aureus infection in vivo. Biofilm, 10(100308), 100308.
DOI Scopus2 WoS2 Europe PMC1
2025 Sunmonu, G. T., Lo, S. W., Sheppard, A. E., & Ogunniyi, A. D. (2025). Serotype replacement and mobile genetic elements in Streptococcus pneumoniae: a systematic review.. Microb Genom, 11(9), 17 pages.
DOI
2025 Nguyen, H. T., Puangseree, J., Nguyen, T. T., Nguyen, M. T., Leigh, C., Venter, H., . . . Ogunniyi, A. D. (2025). Gallium Liquid Metal Nanoparticles as Agents to Treat Multidrug-Resistant Bacterial Infections. Microbiologyopen, 14(5), 14 pages.
DOI
2024 Subramaniam, S., Joyce, P., Ogunniyi, A. D., Dube, A., Sampson, S. L., Lehr, C. M., & Prestidge, C. A. (2024). Minimum Information for Conducting and Reporting In Vitro Intracellular Infection Assays. ACS Infectious Diseases, 10(2), 337-349.
DOI Scopus6 WoS6 Europe PMC6
2024 Ogunniyi, A. D., Venter, H., & Blaskovich, M. A. T. (2024). New antibiotics to combat One Health AMR. Microbiology Australia, 45(2), 74-78.
DOI Scopus2 WoS2
2023 Nguyen, H. T., Venter, H., Woolford, L., Young, K. A., McCluskey, A., Garg, S., . . . Trott, D. J. (2023). Oral administration of a 2-aminopyrimidine robenidine analogue (NCL195) significantly reduces Staphylococcus aureus infection and reduces Escherichia coli infection in combination with sub-inhibitory colistin concentrations in a bioluminescent mouse model. Antimicrobial Agents and Chemotherapy, 67(10), e0042423-1-e0042423-13.
DOI
2023 Ogunniyi, A., Nguyen, H. T., Hansford, K. A., Cooper, M. A., Trott, D. J., & Blaskovich, M. A. T. (2023). Impact of The New Membrane-Targeting Lipoglycopeptide Antibiotic MCC5145 On The Treatment of Bacteremic Pneumococcal Pneumonia In Mice. Microbiology Spectrum, 11(5), e04459-22-1-e04459-22-6.
DOI
2022 Nguyen, H. T., Venter, H., Woolford, L., Young, K., McCluskey, A., Garg, S., . . . Ogunniyi, A. D. (2022). Impact of a novel anticoccidial analogue on systemic staphylococcus aureus infection in a bioluminescent mouse model. Antibiotics, 11(1), 1-16.
DOI Scopus2 WoS2 Europe PMC2
2022 Chai, W. C., Whittall, J. J., Polyak, S. W., Foo, K., Li, X., Dutschke, C. J., . . . Venter, H. (2022). Cinnamaldehyde derivatives act as antimicrobial agents against Acinetobacter baumannii through the inhibition of cell division. Frontiers in Microbiology, 13(967949), 18 pages.
DOI Scopus20 WoS20 Europe PMC16
2022 Blaskovich, M. A. T., Hansford, K. A., Butler, M. S., Ramu, S., Kavanagh, A. M., Jarrad, A. M., . . . Cooper, M. A. (2022). A lipoglycopeptide antibiotic for Gram-positive biofilm-related infections. Science Translational Medicine, 14(662), 1-16.
DOI Scopus10 WoS12 Europe PMC7
2022 Pi, H., Venter, H., Russell, C. C., Young, K. A., McCluskey, A., Page, S. W., . . . Trott, D. J. (2022). In Vitro Activity of Robenidine Analogues NCL259 and NCL265 against Gram-Negative Pathogens. Antibiotics, 11(10), 12 pages.
DOI Scopus2 WoS1
2021 Morshed, M. T., Nguyen, H. T., Vuong, D., Crombie, A., Lacey, E., Ogunniyi, A. D., . . . Piggott, A. M. (2021). Semisynthesis and biological evaluation of a focused library of unguinol derivatives as next-generation antibiotics. Organic and Biomolecular Chemistry, 19(5), 1022-1036.
DOI Scopus11 WoS9 Europe PMC8
2021 Nguyen, H. T., Venter, H., Veltman, T., Williams, R., Anne O'Donovan, L., Russell, C. C., . . . Trott, D. J. (2021). In vitro synergistic activity of NCL195 in combination with colistin against Gram-negative bacterial pathogens. International Journal of Antimicrobial Agents, 57(5), 106323-1-106323-13.
DOI Scopus19 WoS17 Europe PMC16
2021 Nguyen, H. T., O’Donovan, L., Venter, H., Russell, C. C., McCluskey, A., Page, S. W., . . . Ogunniyi, A. D. (2021). Comparison of two transmission electron microscopy methods to visualize drug-induced alterations of gram-negative bacterial morphology. Antibiotics, 10(3), 307.
DOI Scopus19 WoS20 Europe PMC18
2021 André, G. O., Borges, M. T., Assoni, L., Ferraz, L. F. C., Sakshi, P., Adamson, P., . . . Darrieux, M. (2021). Protective role of PhtD and its amino and carboxyl fragments against pneumococcal sepsis.. Vaccine, 39(27), 3626-3632.
DOI Scopus12 WoS10 Europe PMC10
2021 Nguyen, H. T., Morshed, M. T., Vuong, D., Crombie, A., Lacey, E., Garg, S., . . . Ogunniyi, A. D. (2021). Evaluation of Benzguinols as Next-Generation Antibiotics for the Treatment of Multidrug-Resistant Bacterial Infections. Antibiotics, 10(6), 727-1-727-17.
DOI Scopus1
2021 Pi, H., Ogunniyi, A. D., Savaliya, B., Nguyen, H. T., Page, S. W., Lacey, E., . . . Trott, D. J. (2021). Repurposing of the fasciolicide triclabendazole to treat infections caused by staphylococcus spp. and vancomycin-resistant enterococci. Microorganisms, 9(8), 1697-1-1697-20.
DOI Scopus9 WoS7 Europe PMC8
2021 Ogunniyi, A. D., Tenzin, S., Ferro, S., Venter, H., Pi, H., Amorico, T., . . . Trott, D. J. (2021). A pH-neutral electrolyzed oxidizing water significantly reduces microbial contamination of fresh spinach leaves. Food Microbiology, 93(103614), 1-9.
DOI Scopus20 WoS16 Europe PMC5
2021 Ogunniyi, A. D., Dandie, C. E., Brunetti, G., Drigo, B., Aleer, S., Hall, B., . . . Lombi, E. (2021). Neutral electrolyzed oxidizing water is effective for pre-harvest decontamination of fresh produce. Food Microbiology, 93, 10 pages.
DOI Scopus10 WoS7 Europe PMC4
2020 Chai, W. C., Whittall, J. J., Song, D., Polyak, S. W., Ogunniyi, A. D., Wang, Y., . . . Venter, H. (2020). Antimicrobial action and reversal of resistance in MRSA by difluorobenzamide derivatives targeted at FtsZ. Antibiotics (Basel), 9(12), 1-22.
DOI Scopus14 WoS14 Europe PMC9
2020 Dandie, C. E., Ogunniyi, A. D., Ferro, S., Hall, B., Drigo, B., Chow, C. W. K., . . . Lombi, E. (2020). Disinfection options for irrigation water: Reducing the risk of fresh produce contamination with human pathogens. CRITICAL REVIEWS IN ENVIRONMENTAL SCIENCE AND TECHNOLOGY, 50(20), 2144-2174.
DOI Scopus38 WoS33
2020 Tenzin, S., Ogunniyi, A. D., Ferro, S., Deo, P., & Trott, D. J. (2020). Effects of an Eco-Friendly Sanitizing Wash on Spinach Leaf Bacterial Community Structure and Diversity. APPLIED SCIENCES-BASEL, 10(8), 15 pages.
DOI Scopus6 WoS4
2020 Pi, H., Nguyen, H. T., Venter, H., Boileau, A. R., Woolford, L., Garg, S., . . . Ogunniyi, A. D. (2020). In vitro activity of robenidine Analog NCL195 in combination with outer membrane permeabilizers against gram-negative bacterial pathogens and impact on systemic gram-positive bacterial infection in mice. Front Microbiol, 11(1556), 1556.
DOI Scopus18 WoS17 Europe PMC16
2019 Oliver, E., Pope, C., Clarke, E., Langton Hewer, C., Ogunniyi, A., Paton, J., . . . Finn, A. (2019). Th17 responses to pneumococcus in blood and adenoidal cells in children. Clinical and Experimental Immunology, 195(2), 213-225.
DOI Scopus5 WoS5 Europe PMC6
2019 Khazandi, M., Pi, H., Chan, W. Y., Ogunniyi, A. D., Sim, J. X. F., Venter, H., . . . Trott, D. J. (2019). In vitro antimicrobial activity of robenidine, ethylenediaminetetraacetic acid and polymyxin B nonapeptide against important human and veterinary pathogens. Frontiers in Microbiology, 10(837), 837-1-837-15.
DOI Scopus24 WoS22 Europe PMC19
2019 Imani Rad, H., Peeri, H., Amani, M., Mohammadnia, A., Ogunniyi, A. D., Khazandi, M., . . . Arzanlou, M. (2019). Allicin prevents the formation of Proteus-induced urinary crystals and the blockage of catheter in a bladder model in vitro. Microbial Pathogenesis, 132, 293-301.
DOI Scopus6 WoS4 Europe PMC3
2019 Russell, C. C., Stevens, A., Young, K. A., Baker, J. R., McCluskey, S. N., Khazandi, M., . . . McCluskey, A. (2019). Discovery of 4,6-bis(2-((E)-benzylidene)hydrazinyl)pyrimidin-2-Amine with antibiotic activity. ChemistryOpen, 8(7), 896-907.
DOI Scopus5 WoS5 Europe PMC4
2019 Tenzin, S., Ogunniyi, A. D., Khazandi, M., Ferro, S., Bartsch, J., Crabb, S., . . . Trott, D. J. (2019). Decontamination of aerosolised bacteria from a pig farm environment using a pH neutral electrochemically activated solution (Ecas4 anolyte).. PloS one, 14(9), 1-5.
DOI Scopus11 WoS10 Europe PMC7
2019 Ogunniyi, A. D., Dandie, C. E., Ferro, S., Hall, B., Drigo, B., Brunetti, G., . . . Lombi, E. (2019). Comparative antibacterial activities of neutral electrolyzed oxidizing water and other chlorine-based sanitizers. Scientific Reports, 9(1), 19955-1-19955-13.
DOI Scopus27 WoS25 Europe PMC10
2018 Khazandi, M., Al-Farha, A., Coombs, G., O'Dea, M., Pang, S., Trott, D., . . . Petrovski, K. (2018). Genomic characterization of coagulase-negative staphylococci including methicillin-resistant Staphylococcus sciuri causing bovine mastitis. Veterinary Microbiology, 219, 17-22.
DOI Scopus38 WoS33 Europe PMC22
2018 Ogunniyi, A., Kopecki, Z., Hickey, E., Khazandi, M., Peel, E., Belov, K., . . . Trott, D. (2018). Bioluminescent murine models of bacterial sepsis and scald wound infections for antimicrobial efficacy testing. PLoS ONE, 13(7), e0200195-1-e0200195-13.
DOI Scopus27 WoS27 Europe PMC20
2018 Hickey, E., Wong, H., Khazandi, M., Ogunniyi, A., Petrovski, K., Garg, S., . . . Trott, D. (2018). Repurposing Ionophores as novel antimicrobial agents for the treatment of bovine mastitis caused by Gram-positive pathogens. Journal of Veterinary Pharmacology and Therapeutics, 41(5), 746-754.
DOI Scopus19 WoS18 Europe PMC15
2018 Russell, C. C., Stevens, A., Pi, H., Khazandi, M., Ogunniyi, A., Young, K. A., . . . McCluskey, A. (2018). Gram-positive and gram-negative antibiotic activity of asymmetric and monomeric robenidine analogues. ChemMedChem, 13(23), 2573-2580.
DOI Scopus12 WoS12 Europe PMC10
2017 Mahdi, L., Higgins, M., Day, C., Tiralongo, J., Hartley-Tassell, L., Jennings, M., . . . Ogunniyi, A. (2017). The pneumococcal alpha-glycerophosphate oxidase enhances nasopharyngeal colonization through binding to host glycoconjugates. EBioMedicine, 18, 236-243.
DOI Scopus5 WoS4 Europe PMC3
2017 Chai, M., Weiland, F., Harvey, R., Hoffmann, P., Ogunniyi, A., & Paton, J. (2017). Proteomic comparisons of opaque and transparent variants of Streptococcus pneumoniae by two dimensional-differential gel electrophoresis. Scientific Reports, 7(1), 2453-1-2453-11.
DOI Scopus3 WoS3 Europe PMC2
2017 Khazandi, M., Deo, P., Ferro, S., Venter, H., Pi, H., Crabb, S., . . . Trott, D. (2017). Efficacy evaluation of a new water sanitizer for increasing the shelf life of Southern Australian King George Whiting and Tasmanian Atlantic Salmon fillets. Food Microbiology, 68, 51-60.
DOI Scopus35 WoS30 Europe PMC18
2017 Kopecki, Z., Ogunniyi, A. D., Trott, D. J., & Cowin, A. J. (2017). Fighting chronic wound infection - one model at a time. Wound Practice and Research, 25(1), 6-13.
WoS12
2017 Ogunniyi, A., Khazandi, M., Stevens, A., Sims, S., Page, S., Garg, S., . . . Trott, D. (2017). Evaluation of robenidine analog NCL195 as a novel broad-spectrum antibacterial agent. PLoS ONE, 12(9), e0183457-1-e0183457-23.
DOI Scopus39 WoS37 Europe PMC34
2017 Babb, R., Chen, A., Ogunniyi, A., Hirst, T., Kara, E., McColl, S., . . . Paton, J. (2017). Enhanced protective responses to a serotype-independent pneumococcal vaccine when combined with an inactivated influenza vaccine. Clinical Science, 131(2), 169-180.
DOI Scopus20 WoS18 Europe PMC15
2017 Wang, Y., Mowla, R., Guo, L., Ogunniyi, A. D., Rahman, T., De Barros Lopes, M. A., . . . Venter, H. (2017). Evaluation of a series of 2-napthamide derivatives as inhibitors of the drug efflux pump AcrB for the reversal of antimicrobial resistance. Bioorganic and Medicinal Chemistry Letters, 27(4), 733-739.
DOI Scopus35 WoS32 Europe PMC26
2016 Abraham, R., Stevens, A., Young, K., Russell, C., Qvist, A., Khazandi, M., . . . Trott, D. (2016). Robenidine analogues as Gram-positive antibacterial agents. Journal of Medicinal Chemistry, 59(5), 2126-2138.
DOI Scopus30 WoS30 Europe PMC27
2016 Babb, R., Chen, A., Hirst, T., Kara, E., McColl, S., Ogunniyi, A., . . . Alsharifi, M. (2016). Intranasal vaccination with γ -irradiated Streptococcus pneumoniae whole-cell vaccine provides serotype-independent protection mediated by B-cells and innate IL-17 responses. Clinical Science, 130(9), 697-710.
DOI Scopus45 WoS38 Europe PMC36
2015 Iwajomo, O., Moons, P., Nkhata, R., Mzinza, D., Ogunniyi, A., Williams, N., . . . Finn, A. (2015). Delayed reconstitution of B cell immunity to pneumococcus in HIV-infected Malawian children on antiretroviral therapy. Journal of Infection, 70(6), 616-623.
DOI Scopus7 WoS6 Europe PMC6
2015 Le, N. T., Jeong, H. Y., Kwon, H. Y., Ogunniyi, A. D., Paton, J. C., Pyo, S. N., & Rhee, D. K. (2015). Erratum to Modulation of adherence, invasion, and tumor necrosis factor alpha secretion during the early stages of infection by Streptococcus pneumoniae ClpL [Infection and Immunity, 75, 6 (2007) 2996-3005, 2007]. Infection and Immunity, 83(3), 1224.
DOI Scopus1 WoS1 Europe PMC1
2015 Fruzangohar, M., Ebrahimie, E., Ogunniyi, A. D., Mahdi, L. K., Paton, J. C., & Adelson, D. L. (2015). Correction: Comparative GO: A web application for comparative gene ontology and gene ontology-based gene selection in bacteria. Plos One, 10(4), 1 page.
DOI Scopus6 WoS4 Europe PMC3
2015 Knippenberg, S., Ueberberg, B., Maus, R., Bohling, J., Ding, N., Tort Tarres, M., . . . Maus, U. (2015). Streptococcus pneumoniae triggers progression of pulmonary fibrosis through pneumolysin. Thorax, 70(7), 636-646.
DOI Scopus90 WoS86 Europe PMC72
2015 Kara, E., McKenzie, D., Bastow, C., Gregor, C., Fenix, K., Ogunniyi, A., . . . McColl, S. (2015). CCR2 defines in vivo development and homing of IL-23-driven GM-CSF-producing Th17 cells. Nature Communications, 6(8644), 8644-1-8644-1 7.
DOI Scopus114 WoS110 Europe PMC103
2015 Mahdi, L., Van der Hoek, M., Ebrahimie, E., Paton, J., & Ogunniyi, A. (2015). Characterization of pneumococcal genes involved in bloodstream invasion in a mouse model. PLoS One, 10(11), e0141816-1-e0141816-15.
DOI Scopus19 WoS19 Europe PMC18
2014 Mahdi, L., Deihimi, T., Zamansani, F., Fruzangohar, M., Adelson, D., Paton, J., . . . Ebrahimie, E. (2014). A functional genomics catalogue of activated transcription factors during pathogenesis of pneumococcal disease. BMC Genomics, 15(1), 769-1-769-15.
DOI Scopus17 WoS15 Europe PMC16
2014 Plumptre, C., Eijkelkamp, B., Morey, J., Behr, F., Couñago, R., Ogunniyi, A., . . . McDevitt, C. (2014). AdcA and AdcAII employ distinct zinc acquisition mechanisms and contribute additively to zinc homeostasis in Streptococcus pneumoniae. Molecular Microbiology, 91(4), 834-851.
DOI Scopus93 WoS88 Europe PMC86
2014 Manso, A., Chai, M., Atack, J., Furi, L., Croix, M., Haigh, R., . . . Oggioni, M. (2014). A random six-phase switch regulates pneumococcal virulence via global epigenetic changes. Nature Communications, 5(article no. 5055), 5055-1-5055-9.
DOI Scopus185 WoS180 Europe PMC193
2013 Plumptre, C., Ogunniyi, A., & Paton, J. (2013). Vaccination against Streptococcus pneumoniae using truncated derivatives of polyhistidine triad protein D. PLoS One, 8(10), 1-11.
DOI Scopus29 WoS29 Europe PMC26
2013 Iwajomo, O., Finn, A., Ogunniyi, A., Williams, N., & Heyderman, R. (2013). Impairment of pneumococcal antigen specific isotype-switched IgG memory B-cell immunity in HIV infected Malawian adults. PLoS One, 8(11), 1-7.
DOI Scopus11 WoS11 Europe PMC10
2013 Plumptre, C., Ogunniyi, A., & Paton, J. (2013). Surface association of Pht proteins of Streptococcus pneumoniae. Infection and Immunity, 81(10), 3644-3651.
DOI Scopus32 WoS28 Europe PMC25
2013 Mahdi, L., Ebrahimie, E., Adelson, D., Paton, J., & Ogunniyi, A. (2013). A transcription factor contributes to pathogenesis and virulence in streptococcus pneumoniae. PLoS One, 8(8), 1-9.
DOI Scopus14 WoS13 Europe PMC13
2013 Fruzangohar, M., Ebrahimie, E., Ogunniyi, A., Mahdi, L., Paton, J., & Adelson, D. (2013). Comparative GO: a web application for comparative Gene Ontology and Gene Ontology-based gene selection in bacteria. PLoS One, 8(3), 1-8.
DOI Scopus59 WoS57 Europe PMC52
2013 Basavanna, S., Chimalapati, S., Maqbool, A., Rubbo, B., Yuste, J., Wilson, R., . . . Brown, J. (2013). The effects of methionine acquisition and synthesis on Streptococcus pneumoniae growth and virulence. PLoS One, 8(1), 1-14.
DOI Scopus53 WoS55 Europe PMC56
2012 Brumshagen, C., Maus, R., Bischof, A., Ueberberg, B., Bohling, J., Osterholzer, J., . . . Maus, U. (2012). FMS-like tyrosine kinase 3 ligand treatment of mice aggravates acute lung injury in response to Streptococcus pneumoniae: Role of pneumolysin. Infection and Immunity, 80(12), 4281-4290.
DOI Scopus19 WoS19 Europe PMC15
2012 Plumptre, C., Ogunniyi, A., & Paton, J. (2012). Polyhistidine triad proteins of pathogenic streptococci. Trends in Microbiology, 20(10), 485-493.
DOI Scopus49 WoS48 Europe PMC45
2012 Ogunniyi, A., Mahdi, L., Trappetti, C., Verhoeven, N., Mermans, D., Van der Hoek, M., . . . Paton, J. (2012). Identification of genes that contribute to the pathogenesis of invasive Pneumococcal Disease by in vivo transcriptomic analysis. Infection and Immunity, 80(9), 3268-3278.
DOI Scopus56 WoS51 Europe PMC48
2012 Mahdi, L., Wang, H., Van der Hoek, M., Paton, J., & Ogunniyi, A. (2012). Identification of a novel pneumococcal vaccine antigen preferentially expressed during meningitis in mice. Journal of Clinical Investigation, 122(6), 2208-2220.
DOI Scopus45 WoS42 Europe PMC44
2012 Weber, M., Lambeck, S., Ding, N., Henken, S., Kohl, M., Deigner, H., . . . Bauer, M. (2012). Hepatic induction of cholesterol biosynthesis reflects a remote adaptive response to pneumococcal pneumonia. FASEB Journal, 26(6), 2424-2436.
DOI Scopus37 WoS35 Europe PMC29
2012 McAllister, L., Ogunniyi, A., Stroeher, U., & Paton, J. (2012). Contribution of a genomic accessory region encoding a putative cellobiose phosphotransferase system to virulence of Streptococcus Pneumoniae. PLoS One, 7(2), 1-9.
DOI Scopus21 WoS21 Europe PMC19
2011 McAllister, L., Ogunniyi, A., Stroeher, U., Leach, A., & Paton, J. (2011). Contribution of serotype and genetic background to virulence of serotype 3 and serogroup 11 pneumococcal isolates. Infection and Immunity, 79(12), 4839-4849.
DOI Scopus26 WoS25 Europe PMC23
2011 McDevitt, C., Ogunniyi, A., Valkov, E., Lawrence, M., Kobe, B., McEwan, A., & Paton, J. (2011). A molecular mechanism for bacterial susceptibility to zinc. PLoS Pathogens, 7(11), 2357-2365.
DOI Scopus349 WoS333 Europe PMC317
2011 Harvey, R., Ogunniyi, A., Chen, A., & Paton, J. (2011). Pneumolysin with low hemolytic activity confers an early growth advantage to Streptococcus pneumoniae in the blood. Infection and Immunity, 79(10), 4122-4130.
DOI Scopus40 WoS37 Europe PMC33
2011 Iwajomo, O., Finn, A., Moons, P., Nkhata, R., Sepako, E., Ogunniyi, A., . . . Heyderman, R. (2011). Deteriorating pneumococcal-specific B-cell memory in minimally symptomatic African children with HIV infection. The Journal of Infectious Diseases, 204(4), 534-543.
DOI Scopus28 WoS27 Europe PMC28
2011 van Bueren, A., Ficko-Blean, E., Pluvinage, B., Hehemann, J., Higgins, M., Deng, L., . . . Boraston, A. (2011). The conformation and function of a multimodular glycogen-degrading pneumococcal virulence factor. Structure, 19(5), 640-651.
DOI Scopus47 WoS43 Europe PMC36
2011 Trappetti, C., Ogunniyi, A., Oggioni, M., & Paton, J. (2011). Extracellular matrix formation enhances the ability of streptococcus pneumoniae to cause invasive disease. PLoS One, 6(5), 1-17.
DOI Scopus57 WoS50 Europe PMC51
2011 Harvey, R., Stroeher, U., Ogunniyi, A., Smith-Vaughan, H., Leach, A., & Paton, J. (2011). A variable region within the genome of Streptococcus pneumoniae contributes to strain-strain variation in virulence. PLoS One, 6(5), 1-14.
DOI Scopus41 WoS36 Europe PMC38
2011 Ota, M., Oluwalana, C., Howie, S., Gomez, M., Ogunniyi, A., Mendy-Gomez, A., . . . Adegbola, R. (2011). Antibody and T-cell responses during acute and convalescent stages of invasive pneumococcal disease. International Journal of Infectious Diseases, 15(4), E282-E288.
DOI Scopus2 WoS2 Europe PMC2
2011 Paton, J. C., & Ogunniyi, A. D. (2011). Evicting the pneumococcus from Its nasopharyngeal lodgings. Cell host & microbe, 9(2), 89-91.
DOI Scopus2 WoS2 Europe PMC1
2010 Ogunniyi, A., Mahdi, L., Jennings, M., McEwan, A., McDevitt, C., Van der Hoek, M., . . . Paton, J. (2010). Central role of manganese in regulation of stress responses, physiology, and metabolism in Streptococcus pneumoniae. Journal of Bacteriology, 192(17), 4489-4497.
DOI Scopus89 WoS84 Europe PMC80
2010 Henken, S., Bohling, J., Ogunniyi, A., Paton, J., Salisbury, V., Welte, T., & Maus, U. (2010). Evaluation of biophotonic imaging to estimate bacterial burden in mice infected with highly virulent compared to less virulent Streptococcus pneumoniae serotypes. Antimicrobial Agents and Chemotherapy, 54(8), 3155-3160.
DOI Scopus22 WoS21 Europe PMC18
2010 Henken, S., Bohling, J., Martens-Lobenhoffer, J., Paton, J., Ogunniyi, A., Briles, D., . . . Maus, U. (2010). Efficacy profiles of Daptomycin for treatment of Iinvasive and noninvasive pulmonary infections with treptococcus pneumoniae. Antimicrobial Agents and Chemotherapy, 54(2), 707-717.
DOI Scopus33 WoS33 Europe PMC27
2009 Ogunniyi, A., Grabowicz, M., Mahdi, L., Cook, J., Gordon, D., Sadlon, T., & Paton, J. (2009). Pneumococcal histidine triad proteins are regulated by the Zn²⁺-dependent repressor AdcR and inhibit complement deposition through the recruitment of complement factor H. FASEB Journal, 2008(3), 1-8.
DOI Scopus112 WoS102 Europe PMC95
2008 Ogunniyi, A., Paton, J., Kirby, A., McCullers, J., Cook, J., Hyodo, M., . . . Karaolis, D. (2008). C-di-GMP is an effective immunomodulator and vaccine adjuvant against pneumococcal infection. Vaccine, 26(36), 4676-4685.
DOI Scopus80 WoS67 Europe PMC62
2008 Mahdi, L., Ogunniyi, A., Le Messurier, K., & Paton, J. (2008). Pneumococcal Virulence Gene Expression and Host Cytokine Profiles during Pathogenesis of Invasive Disease. Infection and Immunity, 76(2), 646-657.
DOI Scopus55 WoS53 Europe PMC53
2007 Tu, L., Jeong, H., Kwon, H., Ogunniyi, A., Paton, J., Pyo, S., & Rhee, D. (2007). Modulation of adherence invasion and tumor necrosis factor alpha secretion during the early stages of infection by Strepococcus pneumoniae ClpL. Infection and Immunity, 75(6), 2996-3005.
DOI Scopus28 WoS22 Europe PMC24
2007 Ogunniyi, A., Le Messurier, K., Graham, R., Watt, J., Briles, D., Stroeher, U., & Paton, J. (2007). Contributions of pneumolysin, pneumococcal surface protein A (PspA), and PspC to pathogenicity of Streptococcus pneumoniae D39 in a mouse model. Infection and Immunity, 75(4), 1843-1851.
DOI Scopus85 WoS76 Europe PMC67
2007 Ogunniyi, A., Grabowicz, M., Briles, D., Cook, J., & Paton, J. (2007). Development of a vaccine against invasive pneumococcal disease based on combinations of virulence proteins of Streptococcus pneumoniae. Infection and Immunity, 75(1), 350-357.
DOI Scopus170 WoS156 Europe PMC144
2006 Le Messurier, K., Ogunniyi, A., & Paton, J. (2006). Differential expression of key pneumococcal virulence genes in vivo. Microbiology, 152(2), 305-311.
DOI Scopus94 WoS85 Europe PMC80
2004 Kwon, H., Ogunniyi, A., Choi, M., Pyo, S., Rhee, D., & Paton, J. (2004). The ClpP protease of Streptococcus pneumoniae modulates virulence gene expression and protects against fatal pneumococcal challenge. Infection and Immunity, 72(10), 5646-5653.
DOI Scopus99 WoS95 Europe PMC86
2004 McAllister, L., Tseng, H., Ogunniyi, A., Jennings, M., McEwan, A., & Paton, J. (2004). Molecular analysis of the psa permease complex of Streptococcus pneumoniae. Molecular Microbiology, 53(3), 889-901.
DOI Scopus124 WoS114 Europe PMC108
2004 Brown, J. S., Ogunniyi, A. D., Woodrow, M. C., Holden, D. W., & Paton, J. C. (2004). Erratum: Immunization with components of two iron uptake ABC transporters protects mice against systemic Streptococcus pneumoniae infection (Infection and Immunity (2001) 69, 11 (6702-6706)). Infection and Immunity, 72(11), 6755.
DOI Scopus1 WoS1
2003 Chapuy-Regaud, S., Ogunniyi, A., Diallo, N., Huet, Y., Desnottes, J., Paton, J., . . . Trombe, M. (2003). RegR, a global LacI/GalR family regulator, modulates virulence and competence in Streptococcus pneumoniae. Infection and Immunity, 71(5), 2615-2625.
DOI Scopus41 WoS37 Europe PMC35
2003 Stroeher, U., Paton, A., Ogunniyi, A., & Paton, J. (2003). Mutation of luxS of Streptococcus pneumoniae affects virulence in a mouse model. Infection and Immunity, 71(6), 3206-3212.
DOI Scopus85 WoS78 Europe PMC67
2003 Kwon, H., Kim, S., Choi, M., Ogunniyi, A., Paton, J., Park, S., . . . Rhee, D. (2003). Effect of heat shock and mutations in ClpL and ClpP on virulence gene expression in Streptococcus pneumoniae. Infection and Immunity, 71(7), 3757-3765.
DOI Scopus98 WoS97 Europe PMC90
2002 Duthy, T., Ormsby, R., Giannakis, E., Ogunniyi, A., Stroeher, U., Paton, J., & Gordon, D. (2002). The human complement regulator factor H binds pneumococcal surface protein PspC via short consensus repeats 13 to 15. Infection and Immunity, 70(10), 5604-5611.
DOI Scopus75 WoS68 Europe PMC62
2002 Ogunniyi, A., Giammarinaro, P., & Paton, J. (2002). The genes encoding virulence-associated proteins and the capsule of Streptococcus pneumoniae are upregulated and differentially expressed in vivo. Microbiology, 148(Part 7), 2045-2053.
DOI Scopus122 WoS111 Europe PMC99
2002 Ogunniyi, A., Kotlarski, I., Morona, R., & Manning, P. (2002). Epitope analysis of the FanC subunit protein of the K99 (F5) fimbriae of enterotoxigenic Escherichia coli using a recombinant fusion technique. FEMS Immunology and Medical Microbiology, 34(1), 23-31.
DOI Scopus8 WoS7 Europe PMC6
2002 Ogunniyi, A. (2002). Epitope analysis of the FanC subunit protein of the K99 (F5) fimbriae of enterotoxigenic Escherichia coli using a recombinant fusion technique. FEMS Immunology and Medical Microbiology, 34(1), 23-31.
DOI
2001 Ogunniyi, A., Woodrow, M., Poolman, J., & Paton, J. (2001). Protection against Streptococcus pneumoniae elicited by immunization with pneumolysin and CbpA. Infection and Immunity, 69(10), 5997-6003.
DOI Scopus134 WoS118 Europe PMC105
2001 Brown, J., Ogunniyi, A., Woodrow, M., Holden, D., & Paton, J. (2001). Immunization with components of two iron uptake ABC transporters protects mice against systemic Streptococcus pneumoniae infection. Infection and Immunity, 69(11), 6702-6706.
DOI Scopus152 WoS139 Europe PMC124
2000 Ogunniyi, A., Folland, R., Briles, D., Hollingshead, S., & Paton, J. (2000). Immunization of mice with combinations of pneumococcal virulence proteins elicits enhanced protection against challenge with Streptococcus pneumoniae. Infection and Immunity, 68(5), 3028-3033.
DOI Scopus185 WoS168 Europe PMC146
1999 Berry, A., Ogunniyi, A., Miller, D., & Paton, J. (1999). Comparative virulence of Streptococcus pneumoniae strains with insertion-duplication, point, and deletion mutations in the pneumolysin gene. Infection and Immunity, 67(2), 981-985.
DOI Scopus76 WoS73 Europe PMC62
1999 Auzat, I., Chapuy-Regaud, S., Bras, G. L., Santos, D. D., Ogunniyi, A. D., Thomas, I. L., . . . Trombe, M. C. (1999). The NADH oxidase of Streptococcus pneumoniae: Its involvement in competence and virulence. Molecular Microbiology, 34(5), 1018-1028.
DOI Scopus115 WoS108 Europe PMC102
1999 Palmen, R., Ogunniyi, A. D., Berroy, P., Larpin, S., Paton, J. C., & Trombe, M. C. (1999). Insertional mutation of orfD of the DCW cluster of Streptococcus pneumoniae attenuates virulence. Microbial Pathogenesis, 27(6), 337-348.
DOI Scopus5 WoS5 Europe PMC4
1998 Pilling, P. A., Lawrence, M. C., Berry, A. M., Ogunniyi, A. D., Lock, R. A., & Paton, J. C. (1998). Expression, purification and preliminary X-ray crystallographic analysis of PsaA, a putative metal-transporter protein of Streptococcus pneumoniae. Acta Crystallographica Section D Biological Crystallography, 54(6 PART II), 1464-1466.
DOI Scopus30 WoS29 Europe PMC21
1998 Lawrence, M. C., Pilling, P. A., Epa, V. C., Berry, A. M., Ogunniyi, A. D., & Paton, J. C. (1998). The crystal structure of pneumococcal surface antigen PsaA reveals a metal-binding site and a novel structure for a putative ABC-type binding protein. Structure, 6(12), 1553-1561.
DOI Scopus197 WoS184 Europe PMC153
1997 Ogunniyi, A. D., Kotlarski, I., Morona, R., & Manning, P. A. (1997). Role of SefA subunit protein of SEF14 fimbriae in the pathogenesis of Salmonella enterica serovar enteritidis. Infection and Immunity, 65(2), 708-717.
DOI Scopus43 WoS37 Europe PMC27
1997 Ogunniyi, A., Kotlarski, I., Morona, R., & Manning, P. (1997). Role of the SefA subunit protein of SEF14 fimbriae in the pathogenesis of Salmonella enterica serovar Enteritidis. Infection and Immunity, 65(February), 708-717.
1996 Lamikanra, A., Ako-Nai, A. K., & Ogunniyi, D. A. (1996). Transferable antibiotic resistance in Escherichia coli isolated from healthy Nigerian school children. International Journal of Antimicrobial Agents, 7(1), 59-64.
DOI Scopus11 WoS11
1994 Ogunniyi, A. D., Manning, P. A., & Kotlarski, I. (1994). A Salmonella enteritidis 11RX pilin induces strong T-lymphocyte responses. Infection and Immunity, 62(12), 5376-5383.
DOI Scopus36 WoS32 Europe PMC23
1994 Ogunniyi, A. D., Manning, P. A., & Kotlarski, I. (1994). A Salmonella enteritidis 11RX pilin induces strong T-lymphocyte responses. Infection and Immunity, 62(12), 5376-5383.
DOI Scopus36 WoS32 Europe PMC23
1991 Ako-Nai, A. K., Torimiro, S. E. A., Lamikanra, A., & Ogunniyi, A. D. (1991). A survey of nasal carriage of Staphylococcus aureus in a neonatal ward in Ile-Ife, Nigeria. Annals of Tropical Paediatrics, 11(1), 41-45.
DOI Scopus12 WoS6 Europe PMC4
1991 Ako-Nai, A. K., Ogunniyi, A. D., Lamikanra, A., & Torimiro, S. E. A. (1991). The characterisation of clinical isolates of Staphylococcus aureus in Ile-Ife, Nigeria. Journal of Medical Microbiology, 34(2), 109-112.
DOI Scopus24 WoS21 Europe PMC12

Year Citation
2015 Knippenberg, S., Ueberberg, B., Maus, R., Bohling, J., Ding, N., Tarres, M. T., . . . Maus, U. A. (2015). Streptococcus Pneumoniae Triggers Progression Of Pulmonary Fibrosis Through Pneumolysin. In AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE Vol. 191 (pp. 1 page). Denver, CO: AMER THORACIC SOC.

Year Citation
2017 Pi, H., Khazandi, M., Ogunniyi, A. D., Page, S. W., Venter, H., & Trott, D. J. (2017). Characterization of a potential newclass of antimicrobial agent for Gram-negative bacteria. Poster session presented at the meeting of INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS. Taipei, TAIWAN: ELSEVIER SCIENCE BV.
2016 Kopecki, Z., Ogunniyi, A. D., Trott, D., & Cowin, A. J. (2016). Development of novel bioluminescent models of wound infection. Poster session presented at the meeting of Wound repair and regeneration. US: Wiley-Blackwell Publishing.
DOI
2011 Weber, M., Lambeck, S., Ding, N., Henken, S., Kohl, M., Deigner, H. P., . . . Bauer, M. (2011). Hepatic Induction of Cholesterol Biosynthesis Reflects a Remote Adaptive Response to Pneumococcal Pneumonia. Poster session presented at the meeting of INFECTION. SPRINGER HEIDELBERG.

Year Citation
2007 Steinhoff, M. C. (2007). Animal models for protein pneumococcal vaccine evaluation: A summary. Elsevier BV.
DOI

Year Citation
2016 Alsharifi, M., Babb, R., Chen, A. Y., David, S. C., Hirst, T. R., Ogunniyi, A. D., & Paton, J. C. (2016). 050231, Streptococcal Vaccine. Australia.
2016 Alsharifi, M., Babb, R., Chen, A. Y., David, S. C., Hirst, T. R., Ogunniyi, A. D., & Paton, J. C. (2016). 050231, Streptococcal Vaccine. Australia.
2016 Babb, R., Alsharifi, M., Chen, A. Y., David, S. C., Hurst, T. R., Ogunniyi, A. D., & Paton, J. C. (2016). WO2016149771, Streptococcal vaccine.
2016 Babb, R., Alsharifi, M., Chen, A. Y., David, S. C., Hurst, T. R., Ogunniyi, A. D., & Paton, J. C. (2016). WO2016149771, Streptococcal vaccine.
2013 Paton, J., Mahdi, L., & Ogunniyi, A. (2013). WO2013040648, Pneumococcal GLPO immunogen.
2011 Rhee, D. K., Kwon, H. Y., Choi, M. H., Ogunniyi, A. D., & Paton, J. C. (2011). JP4646806, Vaccine comprising a recombinant S. pneumoniae ClpP protein.
2005 Rhee, D., Kwon, H., Choi, M., Ogunniyi, A., & Paton, J. (2005). WO/2005/063283, Vaccine comprising recombinant CIpP protein of streptococcus Pneumoniae. Korea.
Funding Scheme CI/PI/AI Names Amount Funded Years of Funding Project Title
NHMRC Ideas Grant (APP2020758) Ogunniyi A, Garg S, Woolford L, Soares da Costa T $981,046 2023-2025 A novel dual therapy approach to treatment of multidrug-resistant Gram-negative infections
IC220100050: ARC Industrial Transformation Training Centre (ARC ITTC) Blaskovich M (CI) Trott D (CI), Henderson I (CI) Amirali Popat A (CI), Guo J (CI) Elliott A (CI), Soares Magalhaes R (CI), Turni C (CI), Wilson D (CI), Ogunniyi A (CI), Soares da Costa T (CI), Parekh H (CI), Ziora Z (CI), De Cerqueira G (PI), Page S (PI), van Merkestein R (PI), Boot-Handford M (PI), Sceats M (PI), Bright M (PI), Chandrasekaran N (PI) $4,508,426 2023-2027 ARC Training Centre for Environmental and Agricultural Solutions to Antimicrobial Resistance (ARC CEA-StAR)
Contract Research (UA227512); Contracting Party: Invion Limited and RMWC Unlimited Innovation Pty Ltd Ogunniyi AD (CI) Trott DJ (CI)

$74,019

PLUS

Contract Variation 1

($50,713)

 2022-2023 Evaluation of the in vitro antimicrobial activity of 5 photodynamic therapy compounds against Gram-positive, Gram-negative (including periodontitis-causing bacteria) and fungal pathogens.
Research Roadmap Grant Scheme 2021, Faculty of Sciences, The University of Adelaide Wilson DW (CI), O’Handley R (CI), Richter K (CI), Gancheva MR (CI), Ogunniyi AD (CI), Sheppard AE (CI), Ebrahimie E (CI), Abraham R (CI), Trott DJ (CI) $37,000 2022 Deciphering the mechanism of action of a new class of cell membrane-active antimicrobials: a pathway to widespread applications in human and animal health
ICERA DSTG To Neoculi Pty Ltd Page SW (CI), Trott D (CI), Garg S (CI), Ogunniyi AD (CI) $339,963 2021-2022 Tier 2 Priority: Enhanced Human Performance – Operating in CBRN Environments
Contract Research (UA216024); Contracting Party: Zoetis Indonesia Ogunniyi AD (CI) $32,556 2021 Zoetis Lincospectin Checkerboard / FIC studies
Contract Research Variation 1 (UA194233-S02); Contracting Party: Botanix Pharmaceuticals Ltd Ogunniyi AD (CI) $42,594 2019 Cannabidiol MIC and MBC against clinical isolates of canine otitis externa in Australia and time-kill assay against Staphylococcus aureus ATCC 29213
Contract Research (UA194233); Contracting Party: Botanix Pharmaceuticals Ltd Ogunniyi AD (CI) $19,546 2019 Efficacy testing of synthetic cannabidiol in a bioluminescent murine model of Staphylococcus aureus scald wound infection
Contract Research (UA172503); Contracting Party: The University of Queensland Trott D (CI); Ogunniyi AD (CI) $12,000 2018 Efficacy trials of MCC5145 against S. pneumoniae D39 bacteraemia using a bioluminescent intraperitoneal mouse model of sepsis
Contract Research (UA172408); Contracting Party: CSIRO Trott D (CI); Ogunniyi AD (CI) $33,150 2018 Literature Review on the presence of antimicrobial resistance (AMR) in food in Australia and New Zealand
Contract Research (UA183243-S01); Contracting Party: Bayer Australia Ltd Trott D (CI); Ogunniyi AD (CI) $47,911 2018 Mastitis Product Registration (benzyl penicillin) MIC Study
DEBRA Australia Kopecki Z (CI), Cowin A (CI), Vasilev K (CI), Ogunniyi AD (CI) $40,000 2018 Safe and intelligent dressings for treatment of infected wounds
Research Themes Investment Scheme (101796) Seed Funding, University of South Australia Thomas N (CI), Prestidge C (CI), Ogunniyi AD (CI), Kopecki Z (CI), Cowin A (CI), Wormald PJ (PI) $40,000 2018 Re-sensitising resistant bacteria against antibiotics: Giving new power to failing medicines.
Research Themes Investment Scheme, University of South Australia Kopecki Z (CI), Cowin A (CI), Venter H (CI), Garg, S (CI), Coad B (CI) Page, S (PI), Trott D (CI), Ogunniyi AD (PI) $40,000 2018 New in vivo technologies for preclinical assessment of novel antimicrobial drugs against wound infections
Research Themes Investment Scheme Development Funding, University of South Australia Donner E (CI), Short M (CI), Williams C (CI), Ogunniyi AD (CI), Djordjevic S (PI) Reynolds B (PI), King B (PI) $82,788 2018-2020 Antimicrobial resistance burden in migratory and resident bird species in the northern Adelaide coastal zone
Partnership Enabling Grant Scheme, Division of Information Technology Engineering and the Environment, University of South Australia Lombi E (CI), Wedding B (CI), Smith E (CI), Myers B (CI), Condina M (CI), Ogunniyi AD (CI) $36,000 2018 Use of hydrodynamic cavitation for degradation of PFAS, pathogens and antibiotic resistance genes in contaminated waters
ORG121561: AMPC Research Grant; Australian Meat Processor Corporation Trott D (CI); Deo P (co-CI); Khazandi M (co-CI); Ogunniyi A (co-CI) $30,000 2016 Twin Oxide Cabinet Microbiological assessment
FND000138: DIIS - Innovation Connections; Australian Government Department of Industry, Innovation & Science Trott D (CI); Ogunniyi A (co-CI); Khazandi M (co-CI) $100,000 2015-2016 Investigation of ECAS4 technology for improving water quality and shelf life in the seafood industry
ARC Linkage grant JC Paton (CI), AD Ogunniyi (CI), M Alsharifi (PI), TR. Hirst (PI) $275,000 2012-2015 A single vaccine for influenza and pneumonia
Channel 7 Children’s Research Foundation Project Grant AD Ogunniyi (CI), LK Mahdi (AI) $70,000 2012-2013 Molecular analysis of alpha-glycerophosphate oxidase: Role in pneumococcal meningitis
NHMRC Project Grant JC Paton, AD Ogunniyi $1,106,169 2010-2015 Molecular analysis of pneumococcal pathogenesis
Meningitis Research Foundation (UK) AD Ogunniyi, JC Paton, LK Mahdi

UK£196,773

($437,000)

 2008-2011 Characterization and vaccine potential of pneumococcal virulence factors expressed during meningitis
Channel 7 Research Foundation grant UH Stroeher (CI), AD Ogunniyi (AI) $47,000 2008 Characterisation of Virulence Genes of Streptococcus pneumoniae Involved in Otitis Media
NHMRC Equipment Grant JC Paton, R Morona, AW Paton, AD Ogunniyi, AR Jilbert, SR McColl $61,000 2008 Grant to purchase small equipment
Women’s and Children’s Hospital Research Foundation AD Ogunniyi, JC Paton $40,000 2000 Regulation of capsule expression in Streptococcus pneumoniae
Women’s and Children’s Hospital Research Foundation JC Paton, AD Ogunniyi $30,000 1999 Regulation of capsule expression in Streptococcus pneumoniae

 

Although I am a Research-only academic, I gave 2 lectures each to 2nd year Biomed, 3rd year Infection and Immunity A and MSc Biotech students annually from 2011 until the end of 2014 at The University of Adelaide. I was also involved in setting and marking exam questions for 3rd year Infection and Immunity A and MSc Biotech courses and was occasionally involved in tutorials for the MSc Biotech students during that period. I have also given a total of 13 lectures to 3rd year Infection and Immunity students at The University of South Australia (4 lectures in 2017, and 3 lectures each in 2018, 2019 and 2020). Collectively, these activities have allowed me to interact closely with all academic staff, students and colleagues, leading to exchange of ideas and problem solving as well as gaining familiarity with modern approaches to tertiary education and opportunity to attract and recruit prospective Honours, MSc and PhD students.

Date Role Research Topic Program Degree Type Student Load Student Name
2025 Co-Supervisor Integration of Experimental Approaches for Exploration and Development of Novel Antifungal Agents: Addressing Emerging Resistance Challenges Doctor of Philosophy Doctorate Full Time Miss Olivia Pei Ying Oh
2025 Principal Supervisor Identification of pneumococcal serotype-independent antigenic regions and mobile genetic elements driving antimicrobial resistance gene mobility Doctor of Philosophy Doctorate Full Time Mr Gabriel Temitope Sunmonu
2025 Principal Supervisor Identification of pneumococcal serotype-independent antigenic regions and mobile genetic elements driving antimicrobial resistance gene mobility Doctor of Philosophy Doctorate Full Time Mr Gabriel Temitope Sunmonu
2025 Co-Supervisor Integration of Experimental Approaches for Exploration and Development of Novel Antifungal Agents: Addressing Emerging Resistance Challenges Doctor of Philosophy Doctorate Full Time Miss Olivia Pei Ying Oh
2024 Principal Supervisor Preclinical evaluation of new derivatives of the anticoccidial drug robenidine as novel antibacterial agents Doctor of Philosophy Doctorate Full Time Ms Sayara Bista
2024 Co-Supervisor Development of a novel controlled release  anticancer drugs combination system using 3D printing Doctor of Philosophy Doctorate Full Time Songhita Mukhopadhyay
2024 Principal Supervisor Preclinical evaluation of new derivatives of the anticoccidial drug robenidine as novel antibacterial agents Doctor of Philosophy Doctorate Full Time Ms Sayara Bista
2022 Co-Supervisor New antimicrobial formulations and their efficacy for canine otitis externa and other fungal infections. Doctor of Philosophy Doctorate Full Time Bhumi Savaliya
2022 Co-Supervisor New antimicrobial formulations and their efficacy for canine otitis externa and other fungal infections. Doctor of Philosophy Doctorate Full Time Bhumi Savaliya

Date Role Research Topic Program Degree Type Student Load Student Name
2018 - 2022 Co-Supervisor Pre-Clinical In Vitro and In Vivo Testing of Novel Antimicrobials for the Treatment of Bacterial Infections Doctor of Philosophy Doctorate Full Time Ms Hang Thi Nguyen
2012 - 2017 Co-Supervisor Development of a Novel Co-vaccination Approach for Pneumococcal and Influenza Infections Doctor of Philosophy Doctorate Full Time Miss Rachelle Babb
2010 - 2016 Co-Supervisor Characterisation of Streptococcus pneumoniae opacity phase variation Doctor of Philosophy Doctorate Full Time Miss Melissa Hui Chieh Chai
2010 - 2013 Co-Supervisor Molecular Characterisation of the Polyhistidine Triad Proteins of Streptococcus Pneumoniae Doctor of Philosophy Doctorate Full Time Mr Charles Plumptre
2006 - 2010 Co-Supervisor Pathogenesis of Streptococcus pneumoniae Doctor of Philosophy Doctorate Full Time Dr Lauren McAllister
2003 - 2007 Co-Supervisor Differential Expression of Streptococcus Pneumoniae Genes during Pathogenesis Doctor of Philosophy Doctorate Full Time Ms Kim Suk Le Messurier

Date Role Research Topic Location Program Supervision Type Student Load Student Name
2017 - ongoing Co-Supervisor The effect of hospital effluent on the antimicrobial resistance ecology of waste water. University of South Australia - Master - Ms Hong Nguyen

Date Role Committee Institution Country
2023 - ongoing Member Innovation and research sub-committee, South Australian Antimicrobial Resistance Action Plan South Australian Antimicrobial Resistance Action Plan (SAAMRAP) Australia
2022 - 2024 Member The University of Adelaide Animal Ethics Committee (Science) The University of Adelaide Australia
2022 - ongoing Member Australian Society for Microbiology, South Australia Branch Australian Society for Microbiology Australia
2021 - ongoing Member School of Animal and Veterinary Sciences Research Committee The University of Adelaide Australia

Date Role Membership Country
2024 - ongoing Member Australasian Biospecimen Network Association Australia
2021 - ongoing Member Australian Society for Antimicrobials (ASA) Australia
2009 - ongoing Member Australian Society for Microbiology Australia

Connect With Me

External Profiles

Other Links